(Q57942828)

English

Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy

scientific article published on 01 February 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

prostate cancer

1 reference

based on heuristic

inferred from title

Andreas Scorilas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Eleftherios P. Diamandis

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

H Yu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A R Soosaipillai

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A K Gregorakis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Clinica Chimica Acta

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

292

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

127-138

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Prostate-specific Antigen: Its Usefulness in Clinical Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

The Clinical Usefulness of Prostate Specific Antigen: Update 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

The free-to-total serum prostate specific antigen ratio for staging prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

The use of percent free prostate specific antigen for staging clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Serum percent free prostate-specific antigen in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Detection of Prostate Cancer Relapse With Prostate Specific Antigen Monitoring at Levels of 0.001 to 0.1 micro g./l

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

Clinical utility of measurements of free and total prostate-specific antigen (PSA): a review

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900211-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0009-8981(99)00211-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686282%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57942828&oldid=1966840256"